Hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma by Camillo Porta

“…In the August issue of the authoritative Journal of the National Cancer Institute, a research group from Taiwan reported the results of a huge study aimed at assessing a possible association between Hepatitis B virus (HBV) genotypes and common variants in the precore and basal core promoter (BP) regions and the risk of hepatocellular carcinoma (HCC)...…”
Get full text

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment by Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, Vito Racanelli

Subjects: “…hepatocellular carcinoma…”
Get full text

Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinoma by Ling Li, Gilad Halpert, Michael G. Lerner, Haijie Hu, Peter Dimitrion, Matthew J. Weiss, Jin He, Benjamin Philosophe, Richard Burkhart, William R. Burns, Russell N. Wesson, Andrew MacGregor Cameron, Christopher L. Wolfgang, Christos Georgiades, Satomi Kawamoto, Nilofer S. Azad, Mark Yarchoan, Stephen J. Meltzer, Kiyoko Oshima, Laura M. Ensign, Joel S. Bader, Florin M. Selaru

“…Hepatocellular carcinoma (HCC) is the sixth most common and the fourth most deadly cancer worldwide. …”
Get full text

Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside by Gabriel Siracusano, Mariella Tagliamonte, Luigi Buonaguro, Lucia Lopalco

Subjects: “…hepatocellular carcinoma…”
Get full text

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis by Kylie E. Zane, Mina S. Makary

“…Hepatocellular carcinoma is the fourth leading cause of cancer worldwide, and the fastest increasing cause of cancer mortality in the United States. …”
Get full text

Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma by Tiantian Liu, Tiantian Liu, Jianni Qi, Jianni Qi, Jianni Qi, Hao Wu, Hao Wu, Le Wang, Le Wang, Lihui Zhu, Lihui Zhu, Lihui Zhu, Chengyong Qin, Chengyong Qin, Chengyong Qin, Jiao Zhang, Qiang Zhu, Qiang Zhu, Qiang Zhu

Subjects: “…hepatocellular carcinoma…”
Get full text

Little things with significant impact: miRNAs in hepatocellular carcinoma by Jiehan Li, Haolin Bao, Ziyue Huang, Zixin Liang, Mei Wang, Ning Lin, Chunjie Ni, Yi Xu, Yi Xu, Yi Xu, Yi Xu, Yi Xu, Yi Xu, Yi Xu, Yi Xu, Yi Xu, Yi Xu

Subjects: “…hepatocellular carcinoma…”
Get full text

Regulation of TREM1-Mediated Inflammation in Hepatocellular Carcinoma Cells by Vikrant Rai, Devendra K. Agrawal

Subjects: “…hepatocellular carcinoma…”
Get full text

Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells by Tingting Shi, Hisakazu Iwama, Koji Fujita, Hideki Kobara, Noriko Nishiyama, Shintaro Fujihara, Yasuhiro Goda, Hirohito Yoneyama, Asahiro Morishita, Joji Tani, Mari Yamada, Mai Nakahara, Kei Takuma, Tsutomu Masaki

Subjects: Get full text

Nosip is a potential therapeutic target in hepatocellular carcinoma cells by Junjie Gao, Dandan Yang, Zheng Huang, Xueshan Pan, Ruoxue Cao, Chaoqun Lian, Jia Ma, Yuyun Li, Zhiwei Wang, Jun Xia

“…However, the role of Nosip in hepatocellular carcinoma (HCC) is unclear. In this study, Nosip expression was found to be elevated in HCC tissues and cells. …”
Get full text

Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature by Vincent Tambay, Valérie-Ann Raymond, Corentine Goossens, Louise Rousseau, Simon Turcotte, Marc Bilodeau

Subjects: Get full text

Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma by Tingting Liu, Li Liu, Li Li, Jing Cai

Subjects: “…Hepatocellular carcinoma…”
Get full text

Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing by Yi Bai, Dapeng Chen, Chuanliang Cheng, Zhongmin Li, Hao Chi, Yuliang Zhang, Xiaoyu Zhang, Shaohai Tang, Qiang Zhao, Bing Ang, Yamin Zhang

Subjects: Get full text

A Review of Current and Emerging Therapies for Advanced Hepatocellular Carcinoma by Angelica Singh, Sofia Zahid, Ilya Noginskiy, Timothy Pak, Soeb Usta, Marina Barsoum, Uqba Khan

Subjects: “…hepatocellular carcinoma…”
Get full text

Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect by Mohammad Heiat, Hamid Hashemi Yeganeh, Seyed Moayed Alavian, Ehsan Rezaie

Subjects: Get full text

An evolutionary and genomic approach to understand tumor evolution in hepatocellular carcinoma by Kaya, Arife Neslihan

“…Hepatocellular carcinoma (HCC) is one of the deadliest cancer types with diverse etiological factors across the world and very limited treatment options. …”
Get full text

Therapeutic targeting of NAMPT and its associated pathways in hepatocellular carcinoma by Yeo, Joanna Zhen Zhen

“…Hepatocellular carcinoma (HCC) remains a global health challenge that affects more than 700,000 people yearly and has a devastating five-year survival rate at <20%. …”
Get full text

Targeted polymeric therapeutic nanoparticles: Design and interactions with hepatocellular carcinoma by Wang, Qi, Sun, Ying, Zhang, Zhirong, Duan, Yourong

Get full text
Get full text

TACE and Continuous Intraarterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma by Perpustakaan UGM, i-lib

“…Key Words : hepatocellular carcinoma transcatheter arterial chemoembolizati on infusion chemotherapy anticancer drugs angiography…”

Mediastinal Hepatocellular Carcinoma with Unknown Primary: An Unusual and Rare Presentation by Koh, P.S., Yusof, M.M., Yoong, B.K., Rajadurai, P.

“…This is an excerpt from the content Background Hepatocellular carcinoma (HCC) is a common cancer in Asia due to the high prevalence of hepatitis B and C infections in this region [1]. …”